Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Slingsby Brian Taylor
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levy Adam Scott
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Congleton Jon
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Congleton Jon
Mineralys Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Gold Alexander M
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gold Alexander M
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Congleton Jon
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levy Adam Scott
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Karydas Daphne
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director AKKARAJU SRINIVAS
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SBLENDORIO GLENN
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DiRocco Derek
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Slingsby Brian Taylor
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Litzka Olivier
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
No Data